What is the treatment for a paracetamol (acetaminophen) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Paracetamol (Acetaminophen) Overdose

Immediately administer N-acetylcysteine (NAC) to any patient with suspected or confirmed paracetamol overdose when serum levels plot above the treatment line on the Rumack-Matthew nomogram, or when hepatotoxicity is present, or when timing is uncertain—ideally within 8 hours of ingestion to maximize survival and prevent liver failure. 1

Initial Management Within 4 Hours of Ingestion

  • Give activated charcoal (1 g/kg orally) just prior to starting NAC if the patient presents within 4 hours of ingestion, as this significantly reduces paracetamol absorption and lowers subsequent serum concentrations 1, 2
  • Activated charcoal administered within 4 hours reduces paracetamol concentrations by approximately 40% (paracetamol ratio 1.4 vs 2.2 without charcoal) and decreases hepatotoxicity risk 2
  • Ensure airway protection is adequate before administering activated charcoal, particularly with co-ingestions of sedating substances 1

Risk Stratification Using the Rumack-Matthew Nomogram

  • Draw serum paracetamol concentration between 4-24 hours post-ingestion and plot on the Rumack-Matthew nomogram to determine treatment need 1
  • The nomogram uses a treatment line at 150 mg/L at 4 hours (or 50 mg/L at 12 hours) to identify patients requiring NAC 1, 3
  • Start NAC immediately for any patient plotting at or above the "possible toxicity" line—do not wait for repeat levels 1
  • The nomogram is ONLY valid for single acute ingestions with known timing; it does NOT apply to repeated supratherapeutic ingestions, extended-release formulations, or presentations >24 hours post-ingestion 1

NAC Dosing Regimens

Intravenous Protocol (Preferred in Most Settings)

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1
  • Second dose: 50 mg/kg over 4 hours 1
  • Third dose: 100 mg/kg over 16 hours (total 21-hour protocol) 1
  • The newer two-bag regimen (200 mg/kg over 4 hours, then 100 mg/kg over 16 hours) has similar efficacy with significantly fewer adverse reactions 4

Oral Protocol (Alternative)

  • Loading dose: 140 mg/kg orally or via nasogastric tube (diluted to 5% solution) 1
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72-hour protocol) 1
  • The 72-hour oral regimen is as effective as the 20-hour IV regimen and may be superior when treatment is delayed 1

Critical Timing Considerations

  • Treatment within 8 hours results in only 2.9% developing severe hepatotoxicity—this is the golden window 1, 5
  • Efficacy diminishes progressively: 6.1% hepatotoxicity when treated within 10 hours, and 26.4% when treated 10-24 hours post-ingestion 1
  • Never withhold NAC based on timing alone—even late presentations (>24 hours) benefit significantly, with mortality reduction from 80% to 52% in fulminant hepatic failure 1

Special Clinical Scenarios Requiring Immediate NAC

Established Hepatotoxicity or Liver Failure

  • Administer NAC to ALL patients with hepatic failure thought to be due to paracetamol, regardless of time since ingestion (Level B recommendation) 1
  • NAC reduces mortality from 80% to 52%, cerebral edema from 68% to 40%, and need for inotropic support from 80% to 48% in fulminant hepatic failure 1
  • Early NAC treatment (<10 hours) in fulminant hepatic failure results in 100% survival 1

Unknown Time of Ingestion

  • Start NAC immediately for any patient with detectable paracetamol levels and unknown timing 1
  • Base treatment decisions on paracetamol levels and liver function tests rather than the nomogram 1

Repeated Supratherapeutic Ingestions (RSTI)

  • Treat with NAC if serum paracetamol ≥10 mg/mL OR if AST or ALT >50 IU/L 1
  • Consider NAC for ingestions of ≥10 g or 200 mg/kg (whichever is less) in a single 24-hour period 1
  • Also treat if ≥6 g or 150 mg/kg per 24-hour period for ≥48 hours 1

Extended-Release Formulations

  • All potentially toxic modified-release paracetamol ingestions (≥10 g or ≥200 mg/kg) should receive a full course of NAC 4
  • Obtain serial paracetamol levels due to prolonged absorption 1

Massive Overdoses (≥40 g)

  • For paracetamol concentrations more than double the nomogram line, increase NAC dosing 1, 4
  • Most commonly double the third bag dose (100 to 200 mg/kg over 16 hours) 2
  • Increased acetylcysteine dosing in massive overdoses reduces hepatotoxicity risk by 73% (OR 0.27) 2

High-Risk Populations Requiring Lower Treatment Threshold

  • Chronic alcohol users should be treated with NAC even with levels in the "non-toxic" range, as severe hepatotoxicity occurs with doses as low as 4-5 g/day 1
  • Patients with pre-existing liver disease require more conservative treatment thresholds 3
  • Consider treating at lower nomogram levels for patients taking enzyme-inducing drugs 1

Monitoring and Laboratory Assessment

  • Obtain baseline liver function tests (AST, ALT), prothrombin time/INR, and serum paracetamol level 1
  • Repeat liver function tests at 12-24 hours to assess for developing hepatotoxicity 1
  • Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with paracetamol poisoning even without clear overdose history 1

Criteria for Stopping NAC

  • NAC can be discontinued when paracetamol level is undetectable AND liver function tests remain completely normal 1
  • Do NOT stop NAC if any of the following are present: any elevation in AST or ALT above normal, rising transaminases, any coagulopathy, detectable paracetamol level, or clinical signs of hepatotoxicity 1
  • Certain scenarios mandate longer NAC courses: delayed presentation (>24 hours), extended-release formulations, repeated supratherapeutic ingestions, unknown timing with detectable levels, or chronic alcohol use 1

Management of NAC Adverse Reactions

  • Anaphylactoid reactions (hypotension, wheezing, bronchospasm) typically occur during the loading dose 5, 6
  • If reactions occur: stop the infusion, administer antihistamines, then restart at a slower rate 6
  • The two-bag regimen significantly reduces adverse reactions compared to the traditional three-bag protocol 4

Disposition and Transplant Considerations

  • Patients with severe hepatotoxicity (AST >1000 IU/L) or coagulopathy require ICU-level care and immediate transplant hepatology consultation 1
  • Contact a liver transplant center immediately when there is any evidence of liver failure 1
  • Monitor for complications including encephalopathy, coagulopathy, renal failure, and metabolic derangements 1

Critical Pitfalls to Avoid

  • Low or absent paracetamol levels do NOT rule out paracetamol poisoning if ingestion was remote or occurred over several days 1
  • Patients may present with elevated transaminases despite being stratified as "no risk" on the nomogram due to inaccurate history or increased susceptibility 1
  • The nomogram is invalid for presentations >24 hours post-ingestion—base treatment on paracetamol levels and liver function tests instead 1
  • Failing to recognize paracetamol in combination products (opioids, cold medicines) leads to unintentional overdose 3
  • Never delay NAC while waiting for laboratory results in suspected overdose—start empirically and adjust based on results 1

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation and treatment of acetaminophen toxicity.

Advances in pharmacology (San Diego, Calif.), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.